Inhibitory Effect of Morin Against Candida albicans Pathogenicity and Virulence Factor Production: An in vitro and in vivo Approaches
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Candida albicans is considered as an exclusive etiologic agent of candidiasis, a very common fungal infection in human. The expression of virulence factors is highly contributing to the pathogenicity of C. albicans. These factors include biofilm formation, yeast to hyphal transition, adhesins, aspartyl proteases, and phospholipases secretion. Moreover, resistance development is the critical issue for the therapeutic failure of antifungal agents against systemic candidiasis. To circumvent the resistance development, the present study investigated the virulence targeted therapeutic activity of the phyto-bioactive compound morin against C. albicans. Morin, a natural compound commonly found in medicinal plants and widely used in the pharmaceutical and cosmetic products/industries. The present study explicated the significant inhibitory potential of morin against the biofilm formation and other virulence factors production such as yeast-hyphal formation, phospholipase and exopolymeric substances in C. albicans. Further, qPCR analysis confirmed the downregulation of biofilm and virlence-related genes in C. albicans upon morin treatment, which is in correspondence with the in vitro bioassays. Further, the docking analysis revealed that morin shows strong affinity with Hwp-1 protein, which regulates the expression of biofilm as well as hyphal formation in C. albicans and, thereby, abolishes fungal pathogenicity. Moreover, the anti-infective potential of morin against C. albicans associated systemic candidiasis is confirmed through in vivo approach using biomedical model organism zebrafish (Danio rerio). The outcomes of in vivo study demonstrate that the morin treatment effectively rescues animals from C. albicans infections and extends their survival rate by inhibiting the internal colonization of C. albicans. Histopathology analysis revealed an extensive candidiasis-related pathognomonic changes in gills, intestine, and kidney of C. albicans infected animal, while no extensive abnormalities were observed in morin treated animals. The results evidenced that morin has the ability to protect the pathognomonic effect and histopathological lesions caused by C. albicans infection in zebrafish. Thus the present study suggests that the utilization of morin could act as a potent therapeutic medication for C. albicans instigated candidiasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis
Naglik, J. R., Challacombe, S. J., & Hube, B. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.3.400-428.2003 · Cited by 1,179
Development and regulation of single- and multi-species Candida albicans biofilms
Lohse, M. B., Gulati, M., Johnson, A. D., & Nobile, C. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.107 · Cited by 643
Function of Candida albicans Adhesin Hwp1 in Biofilm Formation
Nobile, C. J., Nett, J. E., Andes, D. R., & Mitchell, A. P. (2006) · Eukaryotic Cell · doi:10.1128/ec.00194-06 · Cited by 395
Simple spectrophotometric assay for measuring catalase activity in biological tissues
Hadwan, M. H. (2018) · BMC Biochemistry · doi:10.1186/s12858-018-0097-5 · Cited by 377 · cited 1×
“After incubation, the absorbance of each sample was measured at OD240 nm in order to quantify the catalase activity (Hadwan, 2018).”
MethodEffect of Growth Rate on Resistance of Candida albicans Biofilms to Antifungal Agents
Baillie, G. S., & Douglas, L. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1900 · Cited by 234
Candida albicans biofilm development, modeling a host–pathogen interaction
Nett, J., & Andes, D. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.007 · Cited by 210
Divergent Approaches to Virulence in C. albicans and C. glabrata: Two Sides of the Same Coin
Galocha, M., Pais, P., Cavalheiro, M., Pereira, D., Viana, R., & Teixeira, M. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092345 · Cited by 105 · cited 1×
“albicans is aided by its exclusive virulence factors’ production such as biofilm formation, yeast-hyphal formation, and secretion of proteolytic and lipolytic enzymes (Galocha et al., 2019).”
Background
Cited by
Emerging Antifungal Targets and Strategies
Ivanov, M., Ćirić, A., & Stojković, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052756 · Cited by 160
“albicans hyphal growth, biofilm formation, phospholipase and exopolysaccharide production [82].”
BackgroundRosmarinic acid–Modes of antimicrobial and antibiofilm activities of a common plant polyphenol
Ivanov, M., Kostić, M., Stojković, D., & Soković, M. (2022) · South African Journal of Botany · doi:10.1016/j.sajb.2021.11.050 · Cited by 98
Angusamy, A., Balasubramanian, V., Arunmurugan, B., Arunachalam, K., Issac Abraham, S. V. P., Murugesan, S., Krishnasamy, B., Sundaram, J., & Arumugam, V. R. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03578-4 · Cited by 10
Metadata
- Authors
- Abirami, G., Alexpandi, R., Durgadevi, R., Kannappan, A., & Veera Ravi, A.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2020-10-23
- Volume
- 11
- Pages
- 561298-561298
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W3093656238
- Cited by
- 67
- References
- 8
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.